149 related articles for article (PubMed ID: 6282482)
1. Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
Aisner J; Whitacre M; VanEcho DA; Wesley M; Wiernik PH
Cancer Chemother Pharmacol; 1982; 7(2-3):187-93. PubMed ID: 6282482
[TBL] [Abstract][Full Text] [Related]
2. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
4. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
Daniels JR; Chak LY; Sikic BI; Lockbaum P; Kohler M; Carter SK; Reynolds R; Bohnen R; Gandara D; Yu J
J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
Aisner J; Whitacre MY; Budman DR; Propert K; Strauss G; Van Echo DA; Perry M
Cancer Chemother Pharmacol; 1992; 29(6):435-8. PubMed ID: 1314712
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
10. VP16-213 in combined modality treatment of small cell carcinoma of the lung.
Newman SB; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Raghavan V
Eur J Cancer Clin Oncol; 1982 Apr; 18(4):343-6. PubMed ID: 6288390
[TBL] [Abstract][Full Text] [Related]
11. Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
Cortés Funes H; Dominguez P; Torrubia AP; Lanzos E; Mendez M; Mendiola C
Cancer Chemother Pharmacol; 1982; 7(2-3):181-6. PubMed ID: 6282481
[TBL] [Abstract][Full Text] [Related]
12. Vincristine, Adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung.
von Eyben FE; Arwidi A; Hellekant C; Jonsson K; Lindahl SA; Mattsson W; Tennvall L
Cancer Chemother Pharmacol; 1982; 7(2-3):195-7. PubMed ID: 6282483
[TBL] [Abstract][Full Text] [Related]
13. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
[TBL] [Abstract][Full Text] [Related]
14. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
15. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
[TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
17. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.
Einhorn LH; Crawford J; Birch R; Omura G; Johnson DH; Greco FA
J Clin Oncol; 1988 Mar; 6(3):451-6. PubMed ID: 2832549
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL).
Gracia JM; Jimenez A
Cancer Chemother Pharmacol; 1982; 7(2-3):199-201. PubMed ID: 6282484
[TBL] [Abstract][Full Text] [Related]
20. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
